This trial will test a new device that attempts to measure pain objectively. The device will be applied to patients during routine clinical care to see if it correlates with the patients' verbal pain ratings and analgesia requirements. A brain oxygenation device will be used to monitor brain oxygenation and hemodynamics to see if there is a relationship between the new device's objective measure of pain and brain oxygenation/hemodynamic changes and patient-reported pain.
6 Primary · 13 Secondary · Reporting Duration: 45 minutes
110 Total Participants · 4 Treatment Groups
Primary Treatment: Pain Measurement Device · No Placebo Group · N/A
Age 18 - 45 · Female Participants · 5 Total Inclusion CriteriaMark “Yes” if the following statements are true for you: